Heart Failure (HF) Outpatient Monitoring Evaluation (HOME) Study

NCT01347567 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 145

Last updated 2024-01-03

No results posted yet for this study

Summary

The purpose of this study is to determine if heart failure subjects whose treatment is assisted by home BNP measurements integrated into a home health management system will have better clinical outcomes than subjects whose treatment includes home health management without BNP or than subjects treated by standard care.

Conditions

  • Heart Failure
  • Systolic Heart Failure
  • Acute Decompensated Heart Failure

Interventions

OTHER

Interventions with heart failure medications

Therapeutic interventions with heart failure medications per decision of treating physician for subjects in all study arms but using the different information available in each study arm.

Sponsors & Collaborators

  • Alere San Diego

    lead INDUSTRY

Principal Investigators

  • Kenneth McDonald, Professor · St Vincent's Private Hospitale Ltd, Dublin, Ireland

  • Henry Dargie, Professor · Western Infirmary, Glasgow, UK

  • Theresa McDonagh, Professor · Royal Brompton, London, UK

  • John Atherton, Professor · Royal Brisbane and Women's Hospital, Herston, Australia

  • Henry Krum, Professor · Monash University

  • Richard Thoughton, Professor · University of Otago, Christchurch, New Zealand

  • Rob Doughty, Professor · University of Auckland, Victoria, New Zealand

  • Faiez Zannad, Professor · Institut Lorrain du Coeur et des Vaisseaux, CHU Nancy, Vandoeuvre-les-Nancy, France

  • Ulf Dahlstrom, Professor · Linkoping University Hospital, Sweden

  • P Van der Meer, Doctor · University Medical Center Groningen, the Netherlands

  • Franz Kleber, Professor · Klinikum Ernst von Bergmann, Akademisches Lehrankenhaus der Charite Universitätsmedizin Berlin, Germany

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-03-31
Completion
2014-01-31

Countries

  • Australia
  • Ireland
  • Netherlands
  • New Zealand
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01347567 on ClinicalTrials.gov